Estrogen and Atherosclerosis

Mosca L , Manson JE , Sutherland SE , Langer RD , Manolio T , Barrett-Connor E. Cardiovascular disease in women. A statement for healthcare professionals from the American Heart Association. Circulation 1997;96:2468–82.

American Heart Association. 1998 Heart and stroke facts: statistical update. Dallas: American Heart Association, 1998.

Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet 1998;351:1425–27.

Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? Circulation 1997;95:252–64.

Lobo RA . Hormones, hormone replacement therapy, and heart disease. In: Douglas PA , ed. Cardiovascular health and disease in women. Philadelphia: WB Saunders Company; 1993:153–73.

Hahn R , Eaker E , Rolka H. Reliability of reported age at menopause. Am J Epidemiol 1997;146(9):771–5.

Lidnquist O. Intraindividual changes of blood pressure, serum lipids and body weight in relation to menstrual status: results from a prospective population study of women in Goteborg, Sweden. Prev Med 1982;11:162–72.

Kuller LH , Meilahn EN , Cauley JA , Gutai JP , Matthews KA . Epidemiologic studies of menopause: lessons from the healthy women study. Exp Gerontol 1994;29:337–42.

Matthews KA , Meilahn E , Kuller LH , Kelsey SF , Caggiula AW , Wing RR . Menopause and risk factors for coronary heart disease. N Engl J Med 1989;321:641–6.

Colditz GA , Willett WC , Stampfer MJ , Rosner B , Speizer FE , Hennekens CH . Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105–10.

Guetta V , Cannon RO . Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 1996;93:1928–37.

Gerhard M , Ganz P. How do we explain the clinical benefits of estrogen? Circulation 1995;92:508.

Anderson H.V. Estrogen therapy, atherosclerosis, and clinical cardiovascular events. Circulation. 1996;94:1809–11.

Selzeman CH , Whitehill TA , Shames BD , Pulido ES , Cain BC , Harken AH . The biology of estrogen-mediated repair of cardiovascular injury. Ann Thoracic Surg 1998;65:868–74.

Sacks FM , Campos H , Judge H , Walsh BW . Estrogen treatment and human lipoprotein metabolism. In: Forte TM , ed. Hormonal, metabolic, and cellular influences on cardiovascular disease in women. Armonk, NY: Futura Publishing Company, Inc. 1997:229–46.

Banka C. Antioxidant properties of estrogen. Selective protection of high-density lipoprotein. In: Forte TM , ed. Hormonal, metabolic, and cellular influences on cardiovascular disease in women. Armonk, NY: Futura Publishing Company, Inc. 1993:193–214.

Cannon RO III . Antioxidant effects of estrogen. Administered to postmenopausal women. In: Forte TM , ed. Hormonal, metabolic, and cellular influences on cardiovascular disease in women. Armonk, NY: Futura Publishing Company, Inc.; 1993:215–28.

Espeland MA , Marcovina SM , Miller V , Wood PD , Wasilauskas C , Sherwin R , Schrott H , Bush TL . Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. Circulation 1998;97:979–86.

Bush TL , Barrett-Connor E , Cowan LD , Criqui MH , Wallace RB , Suchindran CM , Tyroler HA , Rifkind BM . Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program follow-up study. Circulation 1987;75:1102–09.

Furchgott RF , Zawadzki JV . The obligatory role of endothelial cells in relation of arterial smooth muscle by acetylcholine. Nature 1980;228:373–6.

Gilligan DM , Quyyumi AA , Cannon RO . Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545–2551.

Vogel RA , Corretti MC . Estrogens, progestins, and heart disease. Can endothelial function divine the benefit? Circulation 1998;97:1223–6.

Williams JK , Adams MR , Klopfenstein S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680–7.

Topol EJ , Califf RM , Van dedWerf F , Simoons M , Hampton J , Lee KL , White H , Simes J , Armstrong P. Perspectives of large-scale cardiovascular clinical trials for the new millennium. Circulation 1997;95:1072–82.

Caine YG , Bauer KA , Barzegar S , et al. Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemost 1992;68:392–5.

Grady D , Rubin SM , Petitti DB , Fox CS , Black D , Ettinger B , Ernster VL , Cummings SR . Hormone replacement therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016–37.

Stampfer MJ , Colditz GA . Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence. Prev Med 1991;20:47–63.

Rossow JE , Finnegan LP , Harlan WR , Pinn VW , Clifford C , McGowan JA . The evolution of the Women's Health Initiative: perspectives from NIH. J Am Med Women Assoc 1995;50:50–5.

Williams JK , Honore EK , Washburn SA , Clarkson TB . Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol 1994;24:1757–61.

Adams MR , Register TC , Golden DL , Wanger JD , Williams JK . Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler. Thromb Vasc Biol 1997;17(1):217–21.

Miyagawa K , Rosch J , Stanczyk E , Hermsmeyer K. Med Roxy progesterone interfers with ovarian steroid protection against coronary vasospasm. Nat Med 1997;3(3):273–4.

Sorensen KE , Dorup I , Hermann AP , Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998;97:1234–8.

The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199–208.

Barrett-Connor E , Grady D. Hormone replacement therapy, heart disease, and other considerations. Annual Review of Public Health 1998;19:55–72.

Grodstein F , Stampfer MJ , Manson JE , Colditz GA , Willett WC , Rosner B , Speizer FE , Hennekens CH . Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453–61.

Sidney S , Petitti DB , Quesenberry CP Jr . Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med 1997;127(7):501–8.

Hemminki E , McPherson K. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ 1997;315:149–53.

Hulley S , Grady D , Bush T , Furberg C , Herrington D , Riggs B , Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605–12.

Petitti DB . Hormone replacement therapy and heart disease prevention. JAMA 1998;280:650–2.